Nifty

:

23349.90

Sensex

:

77155.79

-168.60 (-0.72%)
-422.59 (-0.54%)

Login

Nifty
Sensex

:
:

23349.90
77155.79

-168.60 (-0.72%)
-422.59 (-0.54%)

Sequent Scientific Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

N/A

BSE: 512529 | NSE: SEQUENT

Watchlist

NSE BSE

131.69

05-Jul-2024

Open
High
Low
Previous Close

134.20
134.90
131.35
133.38

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1317587
1753.94
240.70
92.05

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,844.13
293.99
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,221.72
N/A
7.11

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.40
3.04
-1.03

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.60
-18.46
-10.91

PAT CAGR (%)

10 Years
5 Years
3 Years

12.82
-50.72
-65.27

P:E (Median)

8 Years
5 Years
3 Years

31.77
49.51
-

P:BV (Average)

8 Years
5 Years
3 Years

4.04
4.86
4.38

EV:EBITDA (Average)

8 Years
5 Years
3 Years

45.31
57.78
81.81

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 41.99 49.12 -14.52% 57.67 40.42 42.68% 36.77 46.59 -21.08% 42.20 57.00 -25.96%
Expenses 44.09 56.83 -22.42% 59.65 49.49 20.53% 42.51 52.64 -19.24% 46.36 65.75 -29.49%
EBITDA -2.10 -7.71 - -1.98 -9.07 - -5.74 -6.05 - -4.16 -8.75 -
EBIDTM -5.00% -15.70% -3.43% -22.44% -15.61% -12.97% -9.85% -15.34%
Other Income 15.95 9.87 61.60% 10.84 9.70 11.75% 12.97 8.01 61.92% 13.44 7.62 76.38%
Interest 1.00 1.21 -17.36% 0.81 0.98 -17.35% 1.02 0.87 17.24% 1.15 0.72 59.72%
Depreciation 2.12 2.35 -9.79% 2.00 2.43 -17.70% 2.11 2.33 -9.44% 2.05 2.15 -4.65%
PBT 6.41 -1.40 - 6.05 -9.03 - 4.10 -1.23 - 6.09 -3.99 -
Tax 2.15 -0.48 - 1.55 -2.23 - 0.34 0.42 -19.05% 1.51 -2.77 -
PAT 4.26 -0.92 - 4.50 -6.80 - 3.76 -1.65 - 4.58 -1.23 -
PATM 10.15% -1.87% 7.80% -16.82% 10.23% -3.53% 10.85% -2.15%
EPS 0.17 -0.04 - 0.18 -0.27 - 0.15 -0.07 - 0.18 -0.05 -

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 368.65 345.97 6.56% 390.21 333.21 17.11% 361.20 366.67 -1.49% 329.36 375.31 -12.24%
Expenses 329.55 330.84 -0.39% 348.26 341.45 1.99% 328.93 370.04 -11.11% 307.11 364.98 -15.86%
EBITDA 39.10 15.13 158.43% 41.95 -8.24 - 32.27 -3.37 - 22.25 10.34 115.18%
EBIDTM 10.61% 4.37% 10.75% -2.47% 8.93% -0.92% 6.76% 2.75%
Other Income 4.51 1.65 173.33% 2.68 0.79 239.24% 4.00 1.74 129.89% 4.52 2.86 58.04%
Interest 14.29 12.58 13.59% 16.38 10.48 56.30% 12.44 10.87 14.44% 12.58 9.72 29.42%
Depreciation 17.10 15.36 11.33% 16.25 14.24 14.12% 16.48 14.71 12.03% 15.46 13.67 13.09%
PBT 7.90 -3.09 - 12.00 -55.68 - 2.64 -88.80 - 1.49 -10.20 -
Tax 1.56 3.79 -58.84% 2.94 -21.00 - 1.36 3.64 -62.64% -9.18 -0.42 -
PAT 6.34 -6.88 - 9.06 -34.68 - 1.27 -92.44 - 10.68 -9.78 -
PATM 1.72% -1.99% 2.32% -10.41% 0.35% -25.21% 3.24% -2.61%
EPS 0.10 -0.34 - 0.26 -1.40 - -0.04 -0.04 - 0.33 -0.36 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 178.63 168.52 222.69 219.63 265.46 227.33 166.26 271.20 105.87 394.59 444.82 Net Sales Growth -7.51% -24.33% 1.39% -17.26% 16.77% 36.73% -38.69% 156.16% -73.17% -11.29% Cost Of Goods Sold 111.27 107.89 135.92 108.66 108.87 113.04 94.62 161.37 72.47 218.33 229.86 Gross Profit 67.36 60.63 86.77 110.97 156.59 114.29 71.64 109.83 33.40 176.26 214.95 GP Margin 37.71% 35.98% 38.96% 50.53% 58.99% 50.27% 43.09% 40.50% 31.55% 44.67% 48.32% Total Expenditure 192.61 195.18 249.09 231.59 241.50 205.10 163.57 258.06 121.27 359.06 384.54 Power & Fuel Cost - 12.89 13.93 11.96 12.77 12.73 8.52 2.32 2.14 17.98 20.68 % Of Sales - 7.65% 6.26% 5.45% 4.81% 5.60% 5.12% 0.86% 2.02% 4.56% 4.65% Employee Cost - 30.05 36.66 27.38 22.42 17.10 10.71 25.12 17.90 38.84 45.47 % Of Sales - 17.83% 16.46% 12.47% 8.45% 7.52% 6.44% 9.26% 16.91% 9.84% 10.22% Manufacturing Exp. - 22.39 39.30 48.21 58.70 51.52 41.13 15.87 14.85 56.50 48.54 % Of Sales - 13.29% 17.65% 21.95% 22.11% 22.66% 24.74% 5.85% 14.03% 14.32% 10.91% General & Admin Exp. - 12.12 14.79 16.29 15.28 6.90 7.15 13.02 9.92 15.19 23.99 % Of Sales - 7.19% 6.64% 7.42% 5.76% 3.04% 4.30% 4.80% 9.37% 3.85% 5.39% Selling & Distn. Exp. - 1.55 1.85 2.16 4.02 2.11 1.04 0.83 0.47 4.03 5.71 % Of Sales - 0.92% 0.83% 0.98% 1.51% 0.93% 0.63% 0.31% 0.44% 1.02% 1.28% Miscellaneous Exp. - 8.29 6.65 16.94 19.45 1.68 0.40 39.53 3.53 8.19 5.71 % Of Sales - 4.92% 2.99% 7.71% 7.33% 0.74% 0.24% 14.58% 3.33% 2.08% 2.31% EBITDA -13.98 -26.66 -26.40 -11.96 23.96 22.23 2.69 13.14 -15.40 35.53 60.28 EBITDA Margin -7.83% -15.82% -11.86% -5.45% 9.03% 9.78% 1.62% 4.85% -14.55% 9.00% 13.55% Other Income 53.20 45.98 28.29 38.86 31.30 14.56 13.96 24.67 19.07 15.55 3.56 Interest 3.98 4.36 2.51 1.61 2.68 5.04 3.22 4.54 0.42 16.44 47.46 Depreciation 8.28 8.94 9.12 9.59 9.13 8.95 7.22 14.37 3.25 24.18 26.38 PBT 22.65 6.01 -9.75 15.69 43.45 22.81 6.20 18.90 -0.01 10.46 -9.99 Tax 5.55 -0.86 -3.67 0.89 8.77 1.47 -1.38 2.87 0.00 0.07 1.70 Tax Rate 24.50% 358.33% 37.64% 5.67% 21.45% 6.44% -22.26% 0.70% 0.00% 0.67% 3.95% PAT 17.10 0.62 -6.08 14.80 32.11 21.34 7.59 406.41 -0.01 10.39 41.31 PAT before Minority Interest 17.10 0.62 -6.08 14.80 32.11 21.34 7.59 406.41 -0.01 10.39 41.31 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.57% 0.37% -2.73% 6.74% 12.10% 9.39% 4.57% 149.86% -0.01% 2.63% 9.29% PAT Growth 261.32% - - -53.91% 50.47% 181.16% -98.13% - - -74.85% EPS 0.69 0.02 -0.24 0.59 1.29 0.85 0.30 16.28 0.00 0.42 1.66

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,449.42 1,369.73 1,420.91 1,412.82 1,361.62 1,179.24 1,039.31 1,030.59 683.57 624.98 465.36 Net Sales Growth 1.99% -3.60% 0.57% 3.76% 15.47% 13.46% 0.85% 50.77% 9.37% 34.30% Cost Of Goods Sold 784.75 759.74 833.77 793.00 694.65 605.05 543.01 554.23 356.70 311.71 240.72 Gross Profit 664.67 609.98 587.14 619.82 666.96 574.19 496.30 476.36 326.87 313.27 224.65 GP Margin 45.86% 44.53% 41.32% 43.87% 48.98% 48.69% 47.75% 46.22% 47.82% 50.12% 48.27% Total Expenditure 1,313.85 1,308.32 1,408.95 1,303.43 1,151.68 1,008.92 914.37 919.10 643.03 568.27 444.87 Power & Fuel Cost - 35.46 42.45 33.86 28.75 24.73 23.06 14.66 12.77 26.51 23.32 % Of Sales - 2.59% 2.99% 2.40% 2.11% 2.10% 2.22% 1.42% 1.87% 4.24% 5.01% Employee Cost - 250.57 258.38 231.37 187.22 165.06 145.95 132.07 106.22 88.62 62.39 % Of Sales - 18.29% 18.18% 16.38% 13.75% 14.00% 14.04% 12.81% 15.54% 14.18% 13.41% Manufacturing Exp. - 73.58 86.95 93.67 96.18 83.24 77.73 59.07 57.63 72.14 54.31 % Of Sales - 5.37% 6.12% 6.63% 7.06% 7.06% 7.48% 5.73% 8.43% 11.54% 11.67% General & Admin Exp. - 78.10 75.80 66.90 58.40 56.37 58.35 70.92 48.60 36.44 33.79 % Of Sales - 5.70% 5.33% 4.74% 4.29% 4.78% 5.61% 6.88% 7.11% 5.83% 7.26% Selling & Distn. Exp. - 56.70 58.00 57.11 50.00 45.16 36.29 36.87 28.78 17.46 20.27 % Of Sales - 4.14% 4.08% 4.04% 3.67% 3.83% 3.49% 3.58% 4.21% 2.79% 4.36% Miscellaneous Exp. - 54.16 53.60 27.52 36.47 29.32 29.98 51.29 32.34 15.40 20.27 % Of Sales - 3.95% 3.77% 1.95% 2.68% 2.49% 2.88% 4.98% 4.73% 2.46% 2.16% EBITDA 135.57 61.41 11.96 109.39 209.94 170.32 124.94 111.49 40.54 56.71 20.49 EBITDA Margin 9.35% 4.48% 0.84% 7.74% 15.42% 14.44% 12.02% 10.82% 5.93% 9.07% 4.40% Other Income 15.71 10.96 6.39 10.86 10.49 10.09 8.67 17.20 11.08 14.30 9.96 Interest 55.69 48.09 35.52 15.77 24.38 35.71 32.80 39.70 28.34 38.56 44.37 Depreciation 65.29 61.54 55.69 51.54 50.60 50.62 41.92 53.30 40.07 46.22 32.94 PBT 24.03 -37.26 -72.86 52.93 145.45 94.08 58.88 35.70 -16.80 -13.77 -46.85 Tax -3.32 -25.03 -15.68 8.17 32.18 12.03 2.01 13.46 -0.41 2.62 3.39 Tax Rate -13.82% 45.80% 11.39% 15.44% 23.55% 12.79% 3.41% 3.03% 2.44% -19.03% -40.50% PAT 27.35 -35.87 -121.16 40.95 95.44 69.91 48.66 421.57 -13.83 -18.47 -10.74 PAT before Minority Interest 16.47 -29.61 -121.98 44.76 104.45 82.05 56.88 430.83 -16.39 -16.39 -11.76 Minority Interest -10.88 -6.26 0.82 -3.81 -9.01 -12.14 -8.22 -9.26 2.56 -2.08 1.02 PAT Margin 1.89% -2.62% -8.53% 2.90% 7.01% 5.93% 4.68% 40.91% -2.02% -2.96% -2.31% PAT Growth 119.02% - - -57.09% 36.52% 43.67% -88.46% - - - EPS 1.10 -1.44 -4.85 1.64 3.82 2.80 1.95 16.89 -0.55 -0.74 -0.43

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,087.23 1,058.36 1,041.09 1,029.51 886.22 917.79 948.62 1,257.33 1,205.88 156.92 Share Capital 49.89 49.89 49.67 49.67 49.67 49.37 48.75 48.75 47.65 30.48 Total Reserves 960.03 952.25 944.32 972.07 822.45 849.53 882.29 1,193.03 1,134.19 92.50 Non-Current Liabilities -9.38 -9.43 19.26 4.80 11.50 36.20 19.01 38.28 42.08 79.95 Secured Loans 0.00 0.00 0.00 0.00 15.16 20.61 0.00 13.98 23.82 56.70 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.35 Long Term Provisions 2.21 2.54 24.51 6.59 4.09 22.30 24.39 28.88 22.84 22.97 Current Liabilities 98.16 61.61 89.56 96.62 105.24 79.87 26.69 168.71 109.89 427.45 Trade Payables 38.45 36.71 57.56 58.75 64.34 52.60 24.56 69.96 73.64 69.81 Other Current Liabilities 12.64 4.67 5.20 2.85 9.30 6.01 1.91 35.29 20.85 86.85 Short Term Borrowings 46.45 19.10 15.50 5.22 14.39 19.27 0.00 63.22 15.04 270.29 Short Term Provisions 0.61 1.13 11.30 29.81 17.22 1.99 0.21 0.24 0.36 0.51 Total Liabilities 1,176.01 1,110.54 1,149.91 1,130.93 1,002.96 1,033.86 994.32 1,464.32 1,357.85 664.32 Net Block 42.52 56.72 66.90 65.78 69.41 52.42 23.68 181.67 169.60 200.88 Gross Block 87.15 110.96 113.09 102.86 99.30 73.33 37.61 230.34 193.00 302.01 Accumulated Depreciation 44.63 54.24 46.19 37.08 29.89 20.90 13.93 48.67 23.40 101.13 Non Current Assets 1,070.83 1,025.43 995.04 985.95 879.01 946.46 853.77 1,095.85 1,056.39 421.95 Capital Work in Progress 5.14 2.20 1.40 4.34 3.72 0.03 3.12 32.26 19.97 8.93 Non Current Investment 640.30 632.47 658.47 685.11 738.95 788.16 672.67 834.62 834.87 183.11 Long Term Loans & Adv. 382.30 333.48 267.65 230.43 65.53 83.27 138.79 26.79 23.08 26.30 Other Non Current Assets 0.56 0.56 0.61 0.29 1.39 22.57 15.51 20.52 8.86 2.73 Current Assets 96.78 75.02 154.86 144.99 123.95 87.41 140.54 368.46 301.47 242.38 Current Investments 0.11 0.05 0.14 0.07 18.75 0.10 13.98 62.28 62.29 0.08 Inventories 34.54 47.95 67.99 45.79 31.42 25.33 13.83 62.53 56.19 66.88 Sundry Debtors 44.79 13.65 52.42 61.44 40.79 42.90 78.47 113.03 73.75 98.77 Cash & Bank 0.96 0.18 12.89 0.74 3.72 1.88 3.04 3.06 4.80 27.38 Other Current Assets 16.38 1.00 1.74 3.56 29.27 17.21 31.22 127.56 104.45 49.28 Short Term Loans & Adv. 13.54 12.21 19.69 33.40 25.66 15.65 30.09 114.68 86.38 30.28 Net Current Assets -1.38 13.42 65.31 48.37 18.71 7.54 113.85 199.75 191.58 -185.08 Total Assets 1,167.61 1,100.45 1,149.90 1,130.94 1,002.96 1,033.87 994.31 1,464.31 1,357.86 664.33

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 656.56 698.78 692.10 727.65 687.10 706.69 647.58 976.79 945.71 91.27 Share Capital 49.89 49.89 49.67 49.67 49.67 49.37 48.75 48.75 47.65 30.48 Total Reserves 529.37 592.57 595.33 670.21 623.34 638.43 581.25 912.49 874.01 26.85 Non-Current Liabilities 122.08 175.81 209.11 153.58 216.46 214.75 227.13 246.20 299.72 277.55 Secured Loans 123.76 113.95 87.25 62.52 108.88 126.94 85.14 141.76 197.50 249.97 Unsecured Loans 18.96 36.16 35.21 31.18 41.18 20.90 18.40 23.38 13.82 0.35 Long Term Provisions 21.75 21.47 55.95 27.19 13.16 30.50 28.54 34.76 28.66 25.70 Current Liabilities 626.99 558.76 537.35 513.11 514.86 440.41 430.93 663.55 290.37 406.09 Trade Payables 260.26 244.34 258.05 226.91 220.38 209.35 160.49 203.04 143.94 90.94 Other Current Liabilities 109.56 109.57 78.99 100.64 104.98 87.80 106.52 259.26 83.23 107.43 Short Term Borrowings 245.87 182.09 159.54 102.91 147.12 127.36 152.41 194.70 56.04 204.31 Short Term Provisions 11.31 22.76 40.77 82.66 42.38 15.90 11.51 6.54 7.17 3.42 Total Liabilities 1,462.03 1,483.76 1,486.57 1,443.00 1,463.16 1,402.10 1,342.62 1,903.76 1,538.02 921.84 Net Block 591.95 605.31 564.44 535.66 576.57 498.14 475.97 684.33 586.48 474.43 Gross Block 959.12 939.83 825.09 753.25 762.46 638.06 581.74 789.60 643.70 596.25 Accumulated Depreciation 367.17 334.52 260.64 217.60 185.89 139.91 105.77 105.27 57.22 121.82 Non Current Assets 639.17 693.88 678.16 676.33 738.86 795.99 804.61 1,176.02 1,047.48 612.00 Capital Work in Progress 15.93 55.28 11.63 30.79 13.42 22.61 18.04 32.55 23.52 39.06 Non Current Investment 0.89 0.01 36.79 76.94 131.29 179.65 221.73 363.97 360.58 58.04 Long Term Loans & Adv. 18.99 21.74 53.92 32.15 14.40 32.27 31.01 37.51 30.35 36.01 Other Non Current Assets 11.41 11.54 11.37 0.79 3.18 63.31 57.86 57.66 46.54 4.47 Current Assets 810.94 779.79 808.41 766.68 724.30 606.12 538.01 727.74 490.54 309.84 Current Investments 2.61 0.05 1.44 5.66 40.18 0.47 17.34 64.12 66.98 0.58 Inventories 346.23 346.09 347.97 264.36 219.42 200.10 158.57 160.81 135.08 94.36 Sundry Debtors 335.63 340.96 329.24 346.14 318.76 278.25 258.35 254.62 192.39 115.44 Cash & Bank 69.83 41.75 59.25 56.20 75.83 72.04 42.45 47.40 25.30 38.46 Other Current Assets 56.63 7.74 7.68 16.82 70.12 55.26 61.30 200.79 70.80 61.01 Short Term Loans & Adv. 46.26 43.21 62.83 77.52 55.33 46.75 56.05 54.48 46.69 41.86 Net Current Assets 183.95 221.03 271.06 253.57 209.44 165.71 107.08 64.19 200.17 -96.25 Total Assets 1,450.11 1,473.67 1,486.57 1,443.01 1,463.16 1,402.11 1,342.62 1,903.76 1,538.02 921.84

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -26.94 37.75 9.36 2.34 30.20 73.80 -4.02 -24.04 100.02 -24.99 PBT -0.24 -9.75 15.69 43.45 22.81 6.20 409.27 -0.01 10.46 43.01 Adjustment -18.19 -0.49 -6.38 1.12 1.74 -2.19 -392.74 20.30 33.58 22.54 Changes in Working Capital -10.77 48.68 1.81 -25.47 7.84 70.32 -21.10 -42.97 56.92 -89.22 Cash after chg. in Working capital -29.20 38.45 11.12 19.09 32.39 74.34 -4.57 -22.68 100.95 -23.68 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 2.25 -0.70 -1.75 -16.76 -2.19 -0.54 0.55 -1.36 -0.93 -1.31 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 5.47 -50.70 -4.25 16.55 -17.68 -114.06 15.60 -46.84 -359.41 23.65 Net Fixed Assets 20.87 1.33 -7.29 -4.18 -29.66 -32.63 221.87 -49.63 97.97 38.51 Net Investments -7.89 26.09 26.57 72.52 30.56 -101.61 210.25 0.26 -713.97 -118.07 Others -7.51 -78.12 -23.53 -51.79 -18.58 20.18 -416.52 2.53 256.59 103.21 Cash from Financing Activity 22.32 0.24 7.25 -21.33 -10.71 40.34 -11.78 70.97 247.38 7.96 Net Cash Inflow / Outflow 0.84 -12.71 12.36 -2.44 1.81 0.07 -0.19 0.09 -12.01 6.62 Opening Cash & Equivalents 0.08 12.80 0.44 2.87 1.07 1.00 1.19 1.10 13.11 6.48 Closing Cash & Equivalent 0.93 0.08 12.80 0.44 2.87 1.07 1.00 1.19 1.10 13.10

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 30.59 16.81 30.59 114.75 115.33 116.02 45.24 -7.19 -0.05 -23.55 PBT -54.65 -137.66 52.93 145.45 94.08 58.88 445.79 -16.80 -13.77 -8.37 Adjustment 144.97 220.72 93.73 83.98 91.41 84.47 -313.85 123.31 83.81 35.92 Changes in Working Capital -45.67 -51.61 -89.30 -70.89 -58.30 -27.95 -77.87 -104.37 -71.46 -53.98 Cash after chg. in Working capital 44.65 31.45 57.36 158.55 127.18 115.40 54.06 2.14 -1.42 -26.44 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.06 -14.64 -26.77 -43.79 -11.85 0.62 -8.83 -9.33 1.37 2.89 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -5.92 -64.96 -95.57 9.65 -72.27 -67.69 7.17 -116.18 -315.83 -154.69 Net Fixed Assets 20.87 1.33 -7.29 -4.18 -29.66 -32.63 221.87 -49.63 97.97 38.51 Net Investments -7.89 26.09 26.57 72.52 30.56 -101.61 210.25 0.26 -713.97 -118.07 Others -18.90 -92.38 -114.85 -58.69 -73.17 66.55 -424.95 -66.81 300.17 -75.13 Cash from Financing Activity -1.44 32.23 67.26 -138.75 -42.75 -20.08 -56.96 147.44 308.69 179.41 Net Cash Inflow / Outflow 23.24 -15.92 2.29 -14.35 0.31 28.25 -4.55 24.07 -7.19 1.17 Opening Cash & Equivalents 41.57 57.50 53.74 68.10 67.79 39.54 44.10 20.03 21.85 22.96 Closing Cash & Equivalent 64.81 41.57 57.50 53.74 68.10 67.79 39.54 44.10 20.03 21.83

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 40.49 40.18 40.02 41.14 35.11 36.41 38.20 50.95 49.61 8.07 ROA 0.05% -0.54% 1.30% 3.01% 2.10% 0.75% 33.06% 0.00% 1.03% 6.67% ROE 0.06% -0.61% 1.47% 3.39% 2.41% 0.83% 37.41% 0.00% 1.59% 51.35% ROCE 0.37% -0.68% 1.65% 4.45% 2.96% 0.99% 36.09% 0.03% 3.07% 20.15% Fixed Asset Turnover 1.74 2.01 2.04 2.66 2.66 3.00 2.05 0.52 1.65 1.45 Receivable days 61.84 53.54 94.31 69.43 66.55 132.93 127.17 310.76 77.04 70.28 Inventory Days 87.31 93.97 94.25 52.44 45.13 42.89 50.71 197.54 54.96 66.23 Payable days 127.14 126.58 195.35 206.34 103.60 86.82 78.05 239.99 74.47 102.24 Cash Conversion Cycle 22.01 20.93 -6.79 -84.46 8.08 88.99 99.83 268.31 57.53 34.27 Total Debt/Equity 0.05 0.02 0.02 0.01 0.04 0.05 0.00 0.07 0.04 2.77 Interest Cover 0.95 -2.88 10.75 16.26 5.53 2.93 91.09 0.97 1.64 1.91

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 23.22 25.76 25.97 28.98 27.10 27.86 25.85 39.44 38.69 3.76 ROA -2.01% -8.21% 3.06% 7.19% 5.73% 4.14% 26.54% -0.95% -1.33% -1.52% ROE -4.85% -18.95% 6.56% 15.00% 12.06% 8.63% 54.15% -1.74% -3.35% -28.10% ROCE -0.60% -9.71% 7.01% 16.24% 12.59% 9.24% 41.28% 0.87% 2.72% 6.93% Fixed Asset Turnover 1.49 1.65 1.83 1.80 1.72 1.74 1.51 0.96 1.03 1.01 Receivable days 87.51 84.11 85.48 89.12 90.45 92.53 90.49 118.40 87.75 74.80 Inventory Days 89.54 87.10 77.50 64.84 63.56 61.85 56.34 78.37 65.41 73.58 Payable days 121.21 109.97 111.61 117.51 80.72 75.36 77.04 104.11 77.28 87.31 Cash Conversion Cycle 55.84 61.25 51.38 36.45 73.29 79.02 69.78 92.66 75.87 61.07 Total Debt/Equity 0.78 0.62 0.49 0.31 0.51 0.47 0.48 0.43 0.34 8.26 Interest Cover -0.14 -2.88 4.36 6.60 3.63 2.80 12.19 0.41 0.64 0.81

Top Investors:

quant mutual fund - quant small cap fund

ashoka whiteoak icav - ashoka whiteoak india oppor

investor education and protection fund (iepf)

Annual Reports:

News Update:

Sequent Scientific receives WHO prequalification approval for Albendazole API
19th Aug 2024, 17:58 PM

The WHO prequalification recognizes Sequent Scientific’s commitment to stringent international standards in the production of Albendazole API, ensuring efficacy, safety, and quality
Read More
Sequent Scientific - Quarterly Results
14th Aug 2024, 19:49 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback